MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells
Background: MicroRNA-214 ( miR-214 ) has been shown to act as a tumour suppressor in human cervical and colorectal cancer cells. The aim of this study was to experimentally validate high mobility group AT-hook 1 as a novel target for miR-214- mediated suppression of growth and motility. Methods: HMG...
Gespeichert in:
Veröffentlicht in: | British journal of cancer 2016-09, Vol.115 (6), p.741-751 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background:
MicroRNA-214
(
miR-214
) has been shown to act as a tumour suppressor in human cervical and colorectal cancer cells. The aim of this study was to experimentally validate high mobility group AT-hook 1 as a novel target for
miR-214-
mediated suppression of growth and motility.
Methods:
HMGA1
and
miR-214
expression levels were estimated in cervical and colorectal clinical specimens using qPCR.
HMGA1
3′ untranslated region luciferase assays were performed to validate
HMGA1
as a target of
miR-214
. Effect of altering the expression of
miR-214
or
HMGA1
on proliferation, migration and invasion of human cervical and colorectal cancer cells was investigated.
Results:
miR-214
expression was poor while that of
HMGA1
was high in cervical and colorectal cancer tissues.
miR-214
-re-expression or
HMGA1
downregulation inhibited proliferation, migration and invasion of cancer cells while
miR-214
inhibition had opposite effects.
miR-214
was demonstrated to bind to the wild-type 3′ untranslated region of
HMGA1
but not with its mutant.
Conclusions:
Low expression of
miR-214
concurrent with elevated levels of
HMGA1
may contribute to cervical and colorectal cancer progression.
miR-214
-mediated regulation of
HMGA1
is a novel mechanism for its tumour-suppressive actions in human cervical and colorectal cancer cells and opens up avenues for novel therapeutic strategies for these two cancers. |
---|---|
ISSN: | 0007-0920 1532-1827 |
DOI: | 10.1038/bjc.2016.234 |